Basics Curis, Inc. Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge. IPO Date: August 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $21M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.57% Avg Daily Range (30 D): $0.05 | 2.72% Avg Daily Range (90 D): $0.08 | 4.05% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 251 Avg Trade Size (Sh.) (30 D): 175 Avg Trade Size (Sh.) (90 D): 170 Institutional Trades Total Inst.Trades: 619 Avg Inst. Trade: $1.7M Avg Inst. Trade (30 D): $1.07M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.22M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 16.83K     News Aug 5, 2025 @ 10:10 PM Curis (CRIS) Q2 Loss Narrows 66% Source: Jesterai Jul 11, 2024 @ 10:09 AM VISTA Inhibitor Clinical Trials Drug Approval Insi... Source: Kuick Research Apr 12, 2024 @ 12:34 PM Top 3 Health Care Stocks That May Collapse In Q2 Source: Avi Kapoor Apr 5, 2024 @ 12:43 PM Strength Seen in Curis (CRIS): Can Its 19.5% Jump ... Source: Zacks Equity Research Feb 9, 2024 @ 1:11 PM CyberArk Software To Rally Around 19%? Here Are 10... Source: Avi Kapoor Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.63 $-.68 $-1.25 Diluted EPS $-4.63 $-.68 $-1.25 Revenue $ 11.41M $ 2.75M $ 2.38M Gross Profit $ $ $ Net Income / Loss $ -38.92M $ -8.59M $ -10.62M Operating Income / Loss $ -37.97M $ -8.25M $ -10.16M Cost of Revenue $ $ $ Net Cash Flow $ 10M $ M $ M PE Ratio     Splits Sep 29, 2023:   1:20 May 30, 2018:   1:5